Epithalon
Synthetic Pineal Tetrapeptide | Telomerase Activator
DoseGear research brief
Epitalon is a synthetic tetrapeptide developed by Russian scientist Vladimir Khavinson with 35+ years of research. It activates telomerase at extremely low concentrations to maintain telomere length, stimulates melatonin production, and modulates gene expression through epigenetic mechanisms.
Activates telomerase at extremely low concentrations (10⁻¹⁷ to 10⁻¹⁵ M) to maintain telomere length, stimulates melatonin production from the pineal gland, and modulates gene expression through epigenetic mechanisms.
Compound background
Study windows describe what researchers measured, not when an individual should expect a result.
Synthetic tetrapeptide developed in Khavinson-associated pineal research.
Telomerase, circadian biology, and aging models through proposed gene-regulatory and neuroendocrine effects.
A mouse study administered injections from three months of age until natural death. A cited 6–8-year human study used Epithalamin, not Epitalon.
Reference data
Not personalized dosing instructions
Only injectable vial references are shown. Nasal, topical, and unsupported non-vial schedules are excluded.
| Research context | Amount | Frequency | Route |
|---|---|---|---|
| Standard anti-aging | 200-500mcg | 1x daily for 10-20 days | SubQ |
| Conservative start | 100mcg | 1x daily for 10-20 days | SubQ |
| Russian clinical equivalent | 300mcg | 1x daily for 10-20 days | SubQ |
| Ultra-low dose | 50mcg | 1x daily for 10-20 days | SubQ |
Reference cycle
10-20 days per cycle
Reference storage
Lyophilized: 2-8°C refrigerated; Reconstituted: 2-8°C refrigerated, use within 30 days
Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells
Peptides of pineal gland and thymus prolong human life
Synthetic tetrapeptide epitalon restores disturbed neuroendocrine regulation in senescent monkeys
Pineal-regulating tetrapeptide epitalon improves eye retina condition in retinitis pigmentosa
This DoseGear profile combines published scientific literature with lyophilized-vial protocol references. Citations are provided for independent review.
